Sigilon Therapeutics Inc (SGTX)

5.78 +0.36  +6.64% NASDAQ Sep 23, 16:00 5.78 0.00  0.00% After-Hours: 19:01 USD
View Full Chart
Price Chart
View All SGTX News

News

View All Events

Events

Date Type Description
11/15/2021 Earnings Results Q3 2021 Earnings Results
08/10/2021 Earnings Results Q2 2021 Earnings Results
06/24/2021 08:00 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
03/18/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Sigilon Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. It's lead product candidate, SIG-001, prevents bleeding in patients with moderate-severe to severe Hemophilia A.
  • URL: https://www.sigilon.com
  • Investor Relations URL: https://ir.sigilon.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 15, 2021
  • Last Earnings Release: Aug. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.